{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:12Z","timestamp":1789456272035,"version":"build-2803163510"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T00:00:00Z","timestamp":1254960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>\n                    (\n                    <jats:italic>Headache<\/jats:italic>\n                    2010;50:413\u2010419)\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective.\u2014<\/jats:bold>\n                    To assess urinary 6\u2010sulphatoxymelatonin levels in a large consecutive series of patients with migraine and several comorbidities (chronic fatigue, fibromyalgia, insomnia, anxiety, and depression) as compared with controls.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Background.\u2014<\/jats:bold>\n                    Urine analysis is widely used as a measure of melatonin secretion, as it is correlated with the nocturnal profile of plasma melatonin secretion. Melatonin has critical functions in human physiology and substantial evidence points to its importance in the regulation of circadian rhythms, sleep, and headache disorders.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.\u2014<\/jats:bold>\n                    Urine samples were collected into a single plastic container over a 12\u2010hour period from 8:00\n                    <jats:sc>pm<\/jats:sc>\n                    to 8:00\n                    <jats:sc>am<\/jats:sc>\n                    of the next day, and 6\u2010sulphatoxymelatonin was measured by quantitative ELISA. All of the patients were given a detailed questionnaire about headaches and additionally answered the following questionnaires: Chalder fatigue questionnaire, Epworth somnolence questionnaire, State\u2010Trait Anxiety Inventory, and the Beck Depression Inventory.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    A total of 220 subjects were evaluated \u2013 73 (33%) had episodic migraine, 73 (33%) had chronic migraine, and 74 (34%) were enrolled as control subjects. There was a strong correlation between the concentration of 6\u2010sulphatoxymelatonin detected and chronic migraine. Regarding the comorbidities, this study objectively demonstrates an inverse relationship between 6\u2010sulphatoxymelatonin levels and depression, anxiety, and fatigue.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.\u2014<\/jats:bold>\n                    To our knowledge, this is the first study to evaluate the relationship between the urinary concentration of melatonin and migraine comorbidities. These results support hypothalamic involvement in migraine pathophysiology.\n                  <\/jats:p>","DOI":"10.1111\/j.1526-4610.2009.01547.x","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T11:08:07Z","timestamp":1255000087000},"page":"413-419","source":"Crossref","is-referenced-by-count":33,"title":["Urinary 6\u2010Sulphatoxymelatonin Levels Are Depressed in Chronic Migraine and Several Comorbidities"],"prefix":"10.1111","volume":"50","author":[{"given":"Marcelo R.","family":"Masruha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos S.","family":"De Souza Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais S.C.","family":"Minett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Cipolla\u2010Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliova","family":"Zukerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz C.P.","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.P.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3]]},"reference":[{"issue":"44","key":"e_1_2_7_2_2","first-page":"S4","article-title":"Why study the comorbidity of migraine?","volume":"10","author":"Lipton RB","year":"1994","journal-title":"Neurology"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.6.747"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.15.4.367"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04168.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb03882.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00889.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(85)90247-5"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1989.hed22904242.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-008-0047-5"},{"issue":"1","key":"e_1_2_7_11_2","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01172.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(93)90081-P"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330203"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/15.4.376"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(98)00023-0"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_2_7_18_2","first-page":"470","article-title":"Annual changes in 6\u2010sulphatoxymelatonin excretion in man","volume":"117","author":"Bojkowski CJ","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1994.014003205.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1995.015002136.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1997.1707723.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1995.tb00186.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-002-0579-y"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0501fje"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117004"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.02342.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.7.811"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1985.tb02531.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90291-0"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200209000-00004"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199902000-00007"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(99)00071-4"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7901"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00503.x"},{"key":"e_1_2_7_35_2","first-page":"551","article-title":"Normal melatonin levels in patients with fibromyalgia syndrome","volume":"25","author":"Press J","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00548.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2009.01547.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2009.01547.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:19:32Z","timestamp":1762082372000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2009.01547.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1526-4610.2009.01547.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01547.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}